Carnegie Institution and UMASS Medical School Granted Broad U.S. Patent Related to RNA Interference
Research by RNA leaders provides powerful gene-silencing technique Washington, D.C.—The Carnegie Institution for Science and the University of Massachusetts Medical School (UMMS) have been granted United States Patent 8,283,329, entitled, “Genetic inhibition of double-stranded RNA.” The patent, issued on October 9, 2012, is broadly directed to the use of RNA interference (RNAi) to inhibit expression …